FIBROUS DYSPLASIA

Clinical trials for FIBROUS DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new FIBROUS DYSPLASIA trials appear

Sign up with your email to follow new studies for FIBROUS DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope to halt childhood bone disease progression

Disease control Completed

This study tested whether a medication called denosumab could slow or stop the progression of fibrous dysplasia, a rare bone disease, in children. Fifteen children aged 4 to 14 received denosumab injections every four weeks for nearly a year. Researchers measured changes in bone …

Matched conditions: FIBROUS DYSPLASIA

Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

FIBROUS DYSPLASIA

Get alerted when new FIBROUS DYSPLASIA trials appear

New hope to halt childhood bone disease progression